Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

NCT02539966 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Fantom Sirolimus-Eluting Coronary Bioresorbable Scaffold

Sponsor

REVA Medical, Inc.